Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Share-based Compensation (2018 - 2025)

Historic Share-based Compensation for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $2.2 million.

  • Verastem's Share-based Compensation rose 1255.81% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 4162.15%. This contributed to the annual value of $7.3 million for FY2024, which is 2529.01% up from last year.
  • Per Verastem's latest filing, its Share-based Compensation stood at $2.2 million for Q3 2025, which was up 1255.81% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Share-based Compensation registered a high of $3.4 million during Q2 2025, and its lowest value of $1.3 million during Q4 2022.
  • Its 5-year average for Share-based Compensation is $1.9 million, with a median of $1.8 million in 2024.
  • In the last 5 years, Verastem's Share-based Compensation tumbled by 4633.48% in 2021 and then soared by 7916.01% in 2025.
  • Quarter analysis of 5 years shows Verastem's Share-based Compensation stood at $1.6 million in 2021, then decreased by 18.23% to $1.3 million in 2022, then grew by 2.02% to $1.3 million in 2023, then skyrocketed by 53.77% to $2.0 million in 2024, then grew by 7.88% to $2.2 million in 2025.
  • Its Share-based Compensation was $2.2 million in Q3 2025, compared to $3.4 million in Q2 2025 and $1.8 million in Q1 2025.